Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

ECDC has published a new rapid risk assessment discussing ceftazidime-avibactam (CAZ-AVI) resistance. The risk assessment examines the issue in brief, reviews the recent literature reporting resistance of CRE to CAZ-AVI and assesses the risk for the EU/EEA countries.

The risk assessment also outlines options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent the spread of these highly-resistant organisms within healthcare settings and across borders.

Source: ECDC, 13 June 2018